Status:
RECRUITING
Comparative Effectiveness of Individual Versus Group-Level Interventions to Reduce Human Immunodeficiency Virus (HIV)/ Sexually Transmitted Infections (STI) Incidence
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
RAND
The Fenway Institute
Conditions:
HIV
Other STIs
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The HIV diagnosis rate among African-born Black women is the highest of all Black individuals living in the US. Correct and consistent use of condoms and use of pre-exposure prophylaxis (PrEP) are two...
Detailed Description
Background and Significance African immigrants comprise a growing share of the US Black population, particularly in the Northeast. The population of African-born individuals in the US has doubled eve...
Eligibility Criteria
Inclusion
- HIV-negative
- Born in an African country
- Currently living in Greater Boston Area or New York City
- Cis-gender woman
- Self-reported Black or mixed-Black race
- Fluent in English or French
- Ages between 18 and 45
- Report of condomless vaginal or anal sex with one or more male(s) in the last 3 months prior to enrollment
Exclusion
- \- Cis-gender man, transgender woman, transgender man, Pregnant woman
Key Trial Info
Start Date :
November 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
424 Patients enrolled
Trial Details
Trial ID
NCT06022809
Start Date
November 2 2023
End Date
December 31 2025
Last Update
November 20 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
Whittier Street Health Center
Roxbury, Massachusetts, United States, 02120
3
Muslim Women's Insitute for Research and Development
The Bronx, New York, United States, 10452